Synapse - Find an Expert

Results (12)

Alteration of p53 pathway in squamous cell carcinoma of the head and neck: Impact on treatment outcome in patients treated with larynx preservation intent

Journal Article

Osman, I.; Sherman, E.; Singh, B.; Venkatraman, E.; Zelefsky, M.; Bosl, G.; Scher, H.; Shah, J.; Shaha, A.; Kraus, D.; more...
Journal of Clinical Oncology (2002)

Fulltext@MSK | Save

Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer

Journal Article

Morris, M. J.; Akhurst, T.; Osman, I.; Nunez, R.; Macapinlac, H.; Siedlecki, K.; Verbel, D.; Schwartz, L.; Larson, S. M.; Scher, H. I.
Urology (2002)

Fulltext@MSK | Save

HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer

Journal Article

Osman, I.; Scher, H. I.; Drobnjak, M.; Verbel, D.; Morris, M.; Agus, D.; Ross, J. S.; Cordon-Cardo, C.
Clinical Cancer Research (2001)

Fulltext@MSK | Save

Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone

Journal Article

Drobnjak, M.; Osman, I.; Scher, H. I.; Fazzari, M.; Cordon-Cardo, C.
Clinical Cancer Research (2000)

Fulltext@MSK | Save

The development of biologic end points in patients treated with differentiation agents: An experience of retinoids in prostate cancer

Journal Article

Kelly, W. K.; Osman, I.; Reuter, V. E.; Curley, T.; Heston, W. D. W.; Nanus, D. M.; Scher, H. I.
Clinical Cancer Research (2000)

Fulltext@MSK | Save

Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction

Journal Article

Ghossein, R. A.; Osman, I.; Bhattacharya, S.; Ferrara, J.; Fazzari, M.; Cordon-Cardo, C.; Scher, H. I.
Diagnostic Molecular Pathology (1999)

Fulltext@MSK | Save

Inactivation of the p53 pathway in prostate cancer: Impact on tumor progression

Journal Article

Osman, I.; Drobnjak, M.; Fazzari, M.; Ferrara, J.; Scher, H. I.; Cordon-Cardo, C.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer

Journal Article

Lee, C. T.; Capodieci, P.; Osman, I.; Fazzari, M.; Ferrara, J.; Scher, H. I.; Cordon-Cardo, C.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: Alternative pathways of bladder epithelial differentiation and tumor formation